Seema Chugh
- Cancer Research top 10%
- Immunology top 10%
- Galectins and Cancer Biology 4
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research 8
- Cancer Cells and Metastasis 6
-
- Glycosylation and Glycoproteins Research 10
- Epigenetics and DNA Methylation 3
- RNA modifications and cancer 3
- Ubiquitin and proteasome pathways 2
-
- Cancer Research and Treatments 3
- Co-authors
- Moorthy P. PonnusamySurinder K. BatraSatyanarayana RachaganiParthasarathy SeshacharyuluImayavaramban LakshmananDhanya HaridasSaswati KarmakarManeesh Jain
- Cited by
- Cancer ResearchImmunologyOncology
- Partner nations
- United StatesIndia
In The Last Decade
Seema Chugh
20 papers receiving 804 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 179
- Immunology 240
- Oncology 307
- Molecular Biology 615
- Cell Biology 76
Countries citing papers authored by Seema Chugh
This map shows the geographic impact of Seema Chugh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seema Chugh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seema Chugh more than expected).
Fields of papers citing papers by Seema Chugh
This network shows the impact of papers produced by Seema Chugh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seema Chugh. The network helps show where Seema Chugh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Seema Chugh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2022 | 4 | |
| 5 | 2021 | 26 | |
| 6 | 2021 | 21 | |
| 7 | 2020 | 36 | |
| 8 | 2018 | 73 | |
| 9 | 2018 | 42 | |
| 10 | 2018 | 64 | |
| 11 | 2018 | 75 | |
| 12 | 2017 | 1 | |
| 13 | 2017 | 29 | |
| 14 | 2016 | 41 | |
| 15 | 2016 | 59 | |
| 16 | 2015 | 88 | |
| 17 | 2014 | 83 | |
| 18 | 2013 | 9 | |
| 19 | 2013 | 49 | |
| 20 | Myelofibrosis with myeloid metaplasia due to tuberculosis. | 1998 | 1 |
About Seema Chugh
Seema Chugh is a scholar working on Oncology, Biotechnology, Immunology, Cancer Research and Molecular Biology, having authored 23 papers that have together received 811 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (10 papers), Pancreatic and Hepatic Oncology Research (8 papers), Cancer Cells and Metastasis (6 papers), Galectins and Cancer Biology (4 papers), Cancer Research and Treatments (3 papers), Epigenetics and DNA Methylation (3 papers), RNA modifications and cancer (3 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Cancer Research (179 citations), Immunology (240 citations), Oncology (307 citations), Molecular Biology (615 citations) and Cell Biology (76 citations). Seema Chugh has collaborated with scholars based in United States and India. Frequent co-authors include Moorthy P. Ponnusamy, Surinder K. Batra, Satyanarayana Rachagani, Parthasarathy Seshacharyulu, Imayavaramban Lakshmanan, Surinder K. Batra, Dhanya Haridas, Saswati Karmakar, Maneesh Jain and Vinayaga S. Gnanapragassam. Their work appears in journals such as Cancer Research, Neoplasia, British Journal of Cancer, Genes & Cancer and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.